| 标题 |
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cardiovascular Diabetology 作者: ; Michael Roden; Ludwig Merker; Anita Vedel Christiansen; Flavien Roux; et al 出版日期:2015-12-23 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)